FDA Inspection 1021255 — Central Coast Multispecialty Medical Group, Inc.
The FDA completed an inspection of Central Coast Multispecialty Medical Group, Inc. on July 31, 2017 in Monterey, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Monterey, CA (United States)